Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement

Kidney International

Volumn 65, Issue 4, 2004, Pages 1416-1421

  Knight, Eric L ^b   Verhave, Jacobien C ^b   Spiegelman, Donna ^b   Hillege, Hans L ^b   De Zeeuw, Dick ^b   Curhan, Gary C ^b   De Jong, Paul E ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b NONE

Author keywords

Creatinine clearance; PREVEND; Renal function measurement; Serum creatinine; Serum cystatin C

Indexed keywords

CREATININE; CYSTATIN C;

ADULT; AGE; AGED; ARTICLE; BODY HEIGHT; BODY WEIGHT; CIGARETTE SMOKING; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE MARKER; FEMALE; GENDER; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; PROTEIN DETERMINATION;

EID: 1642545149     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00517.x     Document Type: Article

References (36)

1. COCKCROFT DW, GAULT MH: Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41, 1976
2. ABRAHAMSON M, OLAFSSON I, PALSDOTTIR A, et al: Structure and expression of the human cystatin C gene. Biochem J 268:287-294, 1990
3. FINNEY H, NEWMAN DJ, THAKKAR H, et al: Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates, and older children. Arch Dis Child 82:71-75, 2000
4. FINNEY H, NEWMAN DJ, PRICE CP: Adult reference ranges for serum cystatin C, creatinine and predicted creatinine clearance. Ann Clin Biochem 37(Pt 1):49-59, 2000
5. NORLUND L, FEX G, LANKE J, et al: Reference intervals for the glomerular filtration rate and cell-proliferation markers: serum cystatin C and serum beta 2-microglobulin/cystatin C-ratio. Scand J Clin Lab Invest 57:463-470, 1997
6. VINGE E, LINDERGARD B, NILSSON-EHLE P, GRUBB A: Relationships among serum cystatin C, serum creatinine, lean tissue mass and glomerular nitration rate in healthy adults. Scand J Clin Lab Invest 59:587-592, 1999
7. TENSTAD O, ROALD AB, GRUBB A, AUKLAND K: Renal handling of radiolabelled human cystatin C in the rat. Scand J Clin Lab Invest 56:409-414, 1996
8. DHARNIDHARKA VR, KWON C, STEVENS G: Serum cystatin C is superior to serum creatinine as a marker of kidney function: a metaanalysis. Am J Kidney Dis 40:221-226, 2002
9. COLL E, BOTEY A, ALVAREZ L, et al: Serum cystatin C as a new marker for noninvasive estimation of glomerular nitration rate and as a marker for early renal impairment. Am J Kidney Dis 36:29-34, 2000
10. TAN GD, LEWIS AV, JAMES TJ, et al: Clinical usefulness of cystatin C for the estimation of glomerular filtration rate in type 1 diabetes: Reproducibility and accuracy compared with standard measures and iohexol clearance. Diabetes Care 25:2004-2009, 2002
11. ODDOZE C, MORANGE S, PORTUGAL H, et al: Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes. Am J Kidney Dis 38:310-316, 2001
12. MUSSAP M, DALLA VM, FIORETTO P, et al: Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Kidney Int 61:1453-1461, 2002
13. VAN DEN NOORTGATE NJ, JANSSENS WH, DELANGHE JR, et al: Serum cystatin C concentration compared with other markers of glomerular filtration rate in the old. J Am Geriatr Soc 50:1278-1282, 2002
14. CHANTREL F, AGIN A, OFFNER M, et al: Comparison of cystatin C versus creatinine for detection of mild renal failure. Clin Nephrol 54:374-381, 2000
15. PINTO-SIETSMA SJ, JANSSEN WM, HILLEGE HL, et al: Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population. J Am Soc Nephrol 11:1882-1888, 2000
16. PEARSON TA, MENSAH GA, ALEXANDER RW, et al: Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107:499-511, 2003
17. RIBSTEIN J, DU CG, MIMRAN A: Combined renal effects of over-weight and hypertension. Hypertension 26:610-615, 1995
18. PRAGA M, HERNANDEZ E, HERRERO JC, et al: Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int 58:2111-2118, 2000
19. BONNET F, DEPRELE C, SASSOLAS A, et al: Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. Am J Kidney Dis 37:720-727, 2001
20. KASISKE BL, CROSSON JT: Renal disease in patients with massive obesity. Arch Intern Med 146:1105-1109, 1986
21. RITZ E, BENCK U, ORTH SR: Acute effects of cigarette smoking on renal hemodynamics. Contrib Nephrol 130:31-38, 2000
22. GAMBARO G, VERLATO F, BUDAKOVIC A, et al: Renal impairment in chronic cigarette smokers. J Am Soc Nephrol 9:562-567, 1998
23. PANICHI V, MIGLIORI M, DE PIETRO S, et al: C-reactive protein and interleukin-6 levels are related to renal function in predialytic chronic renal failure. Nephron 91:594-600, 2002
24. SHLIPAK MG, FRIED LF, CRUMP C, et al: Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 107:87-92, 2003
25. BUDGE MM, DE JAGER C, HOGERVORST E, SMITH AD: Total plasma homocysteine, age, systolic blood pressure, and cognitive performance in older people. J Am Geriatr Soc 50:2014-2018, 2002
26. GALTEAU MM, GUYON M, GUEGUEN R, SIEST G: Determination of serum cystatin C: Biological variation and reference values. Clin Chem Lab Med 39:850-857, 2001
27. WASÉN E, ISOAHO R, MATTILA K, et al: Serum cystatin C in the aged: Relationships with health status. Am J Kidney Dis 42:36-43, 2003
28. VISSER M, BOUTER LM, MCQILLAN GM, et al: Elevated C-reactive protein levels in overweight and obese adults. JAMA 282:2131-2135, 1999
29. HAK AE, STEHOUWER CD, BOTS ML, et al: Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vasc Biol 19:1986-1991, 1999
30. FROHLICH M, IMHOF A, BERG G, et al: Association between C-reactive protein and features of the metabolic syndrome: A population-based study. Diabetes Care 23:1835-1839, 2000
31. FORD ES: Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care 22:1971-1977, 1999
32. FOLSOM AR, PANKOW JS, TRACY RP, et al: Association of C-reactive protein with markers of prevalent atherosclerotic disease. Am J Cardiol 88:112-117, 2001
33. BERMUDEZ EA, RIFAI N, BURING JE, et al: Relation between markers of systemic vascular inflammation and smoking in women. Am J Cardiol 89:1117-1119, 2002
34. WERLE B, SAUCKEL K, NATHANSON CM, et al: Cystatins C,E/M and F in human pleural fluids of patients with neoplastic and inflammatory lung disorders. Biol Chem 384:281-287, 2003
35. REED CH: Diagnostic applications of cystatin C. Br J Biomed Sci 57:323-329, 2000
36. HANSEN T, PETROW PK, GAUMANN A, et al: Synovial giant cells in rheumatoid arthritis: expression of cystatin C, but not of cathepsin B. Exp Toxicol Pathol 52:312-316, 2000